Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call indicates strong financial performance with increased revenue, net income, and AFFO. Dividend growth and a strategic acquisition pipeline bolster future prospects. Despite a failed acquisition, the company maintains a solid financial position with disciplined debt management. The Q&A highlights confidence in demographic trends and stable rent coverage, outweighing concerns about interest expenses and debt maturities. Overall, the combination of optimistic financial metrics, strategic growth plans, and positive market trends suggests a positive stock price movement in the short term.
Contractual Rent Collection 100% collected in 2025, demonstrating a disciplined investment approach.
New Base Rents $23.3 million annually for 10 Kentucky properties, with a 2.5% annual increase.
Kansas Acquisition Acquired 6 facilities for $24 million, entering a new state.
Missouri Acquisition Acquired 9 skilled nursing facilities for $59 million, adding 686 beds.
Series B Bonds Issued ILS 312 million (~$89.5 million) at a fixed interest rate of 6.7%.
Dividend Increased from $0.14 to $0.16 per share, a 14% increase, representing a 5% yield.
Total Assets $885 million, up $97.9 million or 12.4% year-over-year, driven by acquisitions and retenanting.
Revenue $155 million, up $37.9 million or 32.4% year-over-year, driven by property acquisitions and retenanting.
Net Income $33.3 million ($0.60 per share), up from $26.5 million ($0.57 per share) in 2024.
AFFO $72.5 million, a 29.8% increase year-over-year, with a 13.3% compound annual growth rate.
Adjusted EBITDA $125.3 million, a 38.2% increase year-over-year, with a 13.5% compound annual growth rate.
Net Debt to Net Asset Ratio 49.5% as of December 31, 2025.
Portfolio Value $1.1 billion at acquisition, $1.5 billion based on leases.
Weighted Average Lease Term 7.2 years.
EBITDARM Rent Coverage 2.07 as of November 30, 2025.
New Tenant for Kentucky Properties: Retenanted 10 Kentucky properties with Hill Valley, generating $23.3 million in annual base rents with a 10-year lease term and 2.5% annual increases.
Kansas Market Entry: Acquired 6 facilities with 354 beds for $24 million, entering into a 10-year lease with Advena Healthcare.
Missouri Acquisition: Acquired 9 skilled nursing facilities for $59 million, adding them to existing master leases.
Geographic Expansion: Entered Kansas market and expanded presence in Missouri, diversifying portfolio across 10 states.
Portfolio Value: Portfolio value at acquisition is $1.1 billion, with lease-based valuation closer to $1.5 billion.
Rent Collection: Achieved 100% rent collection for 2025, demonstrating operational stability.
Dividend Increase: Increased dividend by 14% to $0.16 per share in August 2025.
Revenue Growth: 2025 revenue increased by 32.4% to $155 million, driven by acquisitions and lease retenanting.
Investment Approach: Maintained disciplined investment strategy with a 10% cap rate at acquisition.
Debt Management: Issued $89.5 million in bonds and worked on restructuring debt maturities to improve financial flexibility.
Foreign Currency Translation Adjustments: The company experienced a decline in equity due to lower other comprehensive income, driven by foreign currency translation adjustments. This could impact financial stability and investor confidence.
Debt Balances: The company's overall growth in debt balances, driven by financing activities and acquisitions, could pose a risk to financial flexibility and increase interest expenses.
Failed Acquisition: A $90 million acquisition deal fell through, which could hinder the company's growth targets and strategic objectives for 2026.
Interest Expense: Higher interest expenses due to new property acquisitions could offset income growth, impacting net profitability.
Debt Maturity Schedule: The company is working to clean up and push off debt maturities, but unresolved debt issues could create financial strain if not managed effectively.
Market Valuation: The company's stock is undervalued compared to peers, which could affect investor sentiment and capital-raising efforts.
Growth Projections: The company anticipates growth of $100 million to $150 million in acquisitions annually, with a focus on maintaining a disciplined investment approach targeting a 10% capitalization rate at acquisition.
Debt Management: Plans to finalize a term sheet with a bank for an unsecured line of credit and term loan within the next 45 to 60 days, aiming to restructure debt maturities evenly over the next 4-5 years and ensure over $100 million in credit availability.
Portfolio Diversification: The company aims to add 1-2 more states to its portfolio in the coming year, further diversifying its geographic footprint.
Dividend and AFFO Growth: The company expects to maintain a dividend yield of approximately 5% and continue using retained AFFO to pay down debt and fund acquisitions, targeting a blended return of 17-18%.
Market Position: Plans to remain a pure-play skilled nursing facility healthcare REIT, with over 90% of its portfolio in skilled nursing facilities, and continue leveraging its strong rent coverage of over 2x.
Dividend Payment: The company continued to pay a dividend of around 5% during 2025. In Q1, the dividend was $0.14 per share, and in August, the Board of Directors increased it by $0.02 to $0.16 per share, representing a 14% increase.
Dividend Yield: As of December 31, 2025, the dividend yield was 4.9%, with an AFFO payout ratio of 46%.
The earnings call indicates strong financial performance with increased revenue, net income, and AFFO. Dividend growth and a strategic acquisition pipeline bolster future prospects. Despite a failed acquisition, the company maintains a solid financial position with disciplined debt management. The Q&A highlights confidence in demographic trends and stable rent coverage, outweighing concerns about interest expenses and debt maturities. Overall, the combination of optimistic financial metrics, strategic growth plans, and positive market trends suggests a positive stock price movement in the short term.
The earnings call indicates strong financial performance with increased revenue, net income, and dividend growth. The company has a balanced capital structure and plans for further acquisition growth. The Q&A section reveals proactive management strategies, including refinancing plans and strategic divestitures. Despite some unclear responses, the overall sentiment from the earnings and Q&A is positive, bolstered by dividend increases and acquisition plans. The lack of negative sentiment in analyst questions and management's optimistic outlook suggest a positive stock price movement in the short term.
The earnings call presents a positive outlook with strong revenue growth, significant dividend increases, and successful capital raising efforts. Despite the public offering, the company's strategic acquisitions and consistent dividend policy indicate stability and growth. The Q&A section reveals management's confidence in maintaining leverage and securing financing, although there is some uncertainty around Medicaid percentage increases. Overall, the financial performance and strategic initiatives suggest a positive stock price movement in the short term.
The earnings call summary reveals strong financial performance, with increased revenue, net income, and dividends, alongside strategic acquisitions. The Q&A session highlights a robust deal pipeline and confidence in leverage management. While there is uncertainty about the Medicaid payer mix, overall sentiment remains positive due to growth in assets and shareholder returns, despite the public offering potentially diluting shares. The absence of a market cap suggests a neutral to positive reaction, but given the strong financials and optimistic guidance, a 'Positive' sentiment is appropriate.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.